Introduction: Big Organizations, Government Policy and Regulation, and Politics
Leaders of big health care organizations clearly are interested in influencing public policy and government regulation in ways that favor their organizations, and often indirectly themselves. We expect such leaders and organizations to make their policy preferences known. However, increasingly we have found that
Home
»
AstraZeneca
»
conflicts of interest
»
dark money
»
deception
»
GlaxoSmithKline
»
Johnson and Johnson
»
Novartis
»
Pfizer
»
revolving doors
»
Roche
»
Shire
» The Transparency International 2018 Corporate Political Engagement Index- Pharma Appears All Too Comfortable with the Revolving Door and Making Opaque Political Contributions
Subscribe to:
Post Comments (Atom)
Post a Comment